The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia
Clinical trial NCT04422678 · UNKNOWN
Trial details
- NCT number
- NCT04422678
- Sponsor
- Alexandria University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2020-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.